Drug intelligence / Profile preview

dengtaiye total alkaloid

Development stage
Unknown
Lead developer
Kunming Institute of Botany
Modality
Small Molecules
Administration
Oral
01

Overview

Dengtaiye total alkaloid is a purified botanical drug candidate consisting of the total alkaloid fraction extracted from the leaves of *Alstonia scholaris* (L.) R. Br. Developed by the Kunming Institute of Botany (KIB) of the Chinese Academy of Sciences, this therapeutic agent is primarily intended for the treatment of respiratory conditions such as acute tracheobronchitis, post-infectious cough, and bronchial asthma. The extract is rich in indole alkaloids, including scholaricine, vallesamine, and picrinine, which contribute to its multi-target pharmacological profile. It demonstrates potent antitussive, expectorant, and anti-inflammatory effects. Its mechanism of action involves the relaxation of bronchial smooth muscle—potentially through the modulation of L-type calcium channels and muscarinic receptors—and the activation of mu-type opioid receptors to suppress the cough reflex. The drug has progressed through Phase II and Phase III clinical trials in China as a modernized traditional Chinese medicine (TCM) derivative.

Brand names
Dengtaiye Total Alkaloid Capsules
Other names
Alstonia scholaris total alkaloidsTotal alkaloids of Alstonia scholaris leavesDengtaiye total alkaloids
02

Targets

LTCC (Voltage-gated calcium channel (L-type))MOR (Mu opioid receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on dengtaiye total alkaloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dengtaiye total alkaloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call